Medicinal properties of mangosteen (Garcinia mangostana)

Food and Chemical Toxicology

Volumn 46, Issue 10, 2008, Pages 3227-3239

  Pedraza Chaverri, José ^a   Cárdenas Rodríguez, Noemí ^a   Orozco Ibarra, Marisol ^a   Pérez Rojas, Jazmin M ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Garcinia mangostana; Mangosteen; Medicinal properties; Xanthones

Indexed keywords

8 DEOXYGARTANINE; ALPHA MAGOSTIN; GAMMA MANGOSTIN; GARCINIA MANGOSTANA EXTRACT; GARCINONE E; GARTANINE; MANGOSTIN; PLANT EXTRACT; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; GARCINIA MANGOSTANA; PLANT LEAF; REVIEW;

CLUSIACEAE; GARCINIA MANGOSTANA;

EID: 52949137354     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.07.024     Document Type: Review

References (113)

1. Ampofo S.A., and Waterman P.G. Xanthones and neoflavonoids from two Asian species of Calophyllum. Phytochemistry 25 (1986) 2617-2620
2. Asai F., Iinuma M., Tanaka T., and Tosa H. A xanthone from pericarps of Garcinia mangostana. Phytochemistry 39 (1995) 943-944
3. Azebaze A.G.B., Meyer M., Valentin A., Nguemfo E.L., Fomum Z.T., and Nkengfack A.E. Prenylated xanthone derivatives with antiplasmodial activity from Allanblackia monticola. Chem. Pharm. Bull. 54 (2006) 111-113
4. Balasubramanian K., and Rajagopalan K. Novel xanthones from Garcinia mangostana, structures of BR-xanthone-A and BR-xanthone-B. Phytochemistry 27 (1988) 1552-1554
5. Bennett G.J., and Lee H.H. Xanthones from Guttiferae. Phytochemistry 28 (1989) 967-998
6. Caius J. The Medicinal and Poisonous Plants of India (2003), Scientific Publishers, India p. 527
7. Chairungsilerd N., Furukawa K.I., Ohta T., Nozoe S., and Ohizumi Y. Pharmacological properties of α-mangostin, a novel histamine H1 receptor antagonist. Eur. J. Pharmacol. 314 (1996) 351-356
8. Chairungsrilerd N., Takeuchi K., Ohizumi Y., Nozoe S., and Ohta T. Mangostanol, a prenyl xanthone from Garcinia mangostana. Phytochemistry 43 (1996) 1099-1102
9. Chairungsrilerd N., Furukawa K., Ohta T., Nozoe S., and Ohizumi Y. Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana. Planta Med. 62 (1996) 471-472
10. Chairungsrilerd N., Furukawa K., Tadano T., Kisara K., and Ohizumi Y. Effect of γ-mangostin through the inhibition of 5-hydroxy-tryptamine2A receptors in 5-fluoro-alpha-methyltryptamine-induced head-twitch responses of mice. Br. J. Pharmacol. 123 (1998) 855-862
11. Chairungsrilerd N., Furukawa K.I., Ohta T., Nozoe S., and Ohizumi Y. Γ-Mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 357 (1998) 25-31
12. Chanarat P., Chanarat N., Fujihara M., and Nagumo T. Immunopharmacological activity of polysaccharide from the pericarb of mangosteen garcinia: phagocytic intracellular killing activities. J. Med. Assoc. Thai. 80 (1997) S149-S154
13. Chen S., Wan M., and Loh B.N. Active constituents against HIV-1 protease from Garcinia Mangostana. Planta Med. 62 (1996) 381-382
14. Chen L.G., Yang L.L., and Wang C.C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 46 (2008) 688-693
15. Chiang L.C., Cheng H.Y., Liu M.C., Chiang W., and Lin C.C. In vitro evaluation of antileukemic activity of 17 commonly used fruits and vegetables in Taiwan. Lebensm. Wiss. Technol. 37 (2004) 539-544
16. Chin Y.W., Jung H.A., Chai H., Keller W.J., and Kinghorn A.D. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen). Phytochemistry 69 (2008) 754-758
17. Chirino Y.I., Orozco-Ibarra M., and Pedraza-Chaverri J. Evidencia de la participación del peroxinitrito en diversas enfermedades. Rev. Invest. Clin. 58 (2006) 350-358
18. Chomnawang M.T., Sakagami S.S., Nukoolkarn V.S., and Gritsanapan W. Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria. J. Ethnopharmacol. 101 (2005) 330-333
19. Chomnawang M.T., Surassmo S., Nukoolkarn V.S., and Gritsanapan W. Effect of Garcinia mangostana on inflammation caused by Propionibacterium acnes. Fitoterapia 78 (2007) 401-408
20. Chopra R.N., Nayar S.L., and Chopra I.C. Glossary of Indian Medicinal Plants (1956), The National Institute of Science Communication and Information Resources, Nueva Delhi, India p. 123
21. Deschamps J.D., Gautschi J.T., Whitman S., Johnson T.A., Gassner N.C., Crews P., and Holman T.R. Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorg. Med. Chem. 15 (2007) 6900-6908
22. Devi Sampath P., and Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J. Biochem. Mol. Toxicol. 21 (2007) 336-339
23. Dharmaratne H.R., Wijesinghe W.M., and Thevanasem V. Antimicrobial activity of xanthones from Calophyllum species, against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 66 (1999) 339-342
24. Dragendorff O. Über das Harz von Garcinia Mangostana L. Liebigs. Ann. 482 (1930) 280-301
25. Dutta P., Sem A., Sarkar K., and Banerji N. Acid-catalysed cyclisations of xanthones: structure of a new xanthone from Garcinia mangostana Linn. Indian J. Chem. 26B (1987) 281-282
26. Ee G.C.L., Daud S., Taufiq-Yap Y.H., Ismail N.H., and Rahmani M. Xanthones from Garcinia mangostana (Guttiferae). Nat. Prod. Res. 20 (2006) 1067-1073
27. Fan C., and Su J. Antioxidative mechanism of isolated components from methanol extrac of fruit hulls of G. Mangostana L. J. Chinese Agr. Chem. Soc. 35 (1997) 540-551
28. Gales L., and Damas A.M. Xanthones-a structural perspective. Curr. Med. Chem. 12 (2005) 2499-2515
29. Garcia V.V., Magpantay T.O., and Escobin L.D. Antioxidant potential of selected Philippine vegetables and fruits. Philipp. Agr. Sci. 88 (2005) 78-83
30. Garnett M., and Sturton S.D. Garcinia Mangostana in the treatment of amoebic dysentery. Chin. Med. J. XLVI (1932) 969-973
31. Gopalakrishnan G., and Balaganesan B. Two novel xanthones from Garcinia mangostana. Fitoterapia 71 (2000) 607-609
32. Gopalakrishnan C., Shankaranarayanan D., Kameswaran L., and Nazimudeen S.K. Effect of mangostin, a xanthone from Garcinia mangostana Linn. in immunopathological and inflammatory reactions. Indian J. Exp. Biol. 18 (1980) 843-846
33. Gopalakrishnan G., Banumathi B., and Suresh G. Evaluation of the antifungal activity of natural xanthones from the fruits of Garcinia mangostana and their synthetic derivatives. J. Nat. Prod. 60 (1997) 519-524
34. Govindachari T.R.K.P., and Muthukumaraswamy N. Xanthones of Garcinia Mangostana Linn. Tetrahedron 27 (1971) 3919-3926
35. Harbone J., Baxter H., and Moss G. Phytochemical Dictionary - A Handbook of Bioactive Compounds from Plants (1999), Taylor & Francis p. 590
36. Haruenkit R., Poovarodom S., Leontowicz H., Leontowicz M., Sajewicz M., Kowalska T., Delgado E., Rocha N.E., Gallegos J.A., Trakhtenberg S., and Gorinstein S. Comparative study of health properties and nutritional value of durian, mangosteen and sneke fruit: Experiments in vitro and in vivo. J. Agric. Food Chem. 55 (2007) 5842-5849
37. Hasegawa, H., Sasaki, S., Almi, N., Takayama, H., Koyano, T., 1996. Helycobacter pylori inhibitors containing xanthones from Garcinia mangostana. Japanese patent No. JP 08231396.
38. Ho C.K., Huang Y.L., and Chen C.C. Garcinone E, a xanthone derivative, has potent cytotoxic effect against the hepatocellular carcinoma cell lines. Planta Med. 68 (2002) 975-979
39. Holloway D.M., and Scheinmann F. Phenolic compounds from the heartwood of Garcinia mangostana. Phytochemistry 14 (1975) 2517-2518
40. Huang Y.L., Chen C.C., Chen Y.J., Huang R.L., and Shieh B.J. Three xanthones and a benzophenone from Garcinia mangostana. J. Nat. Prod. 64 (2001) 903-906
41. Iinuma M., Tosa H., Tanaka T., Asai F., Kobayashi Y., Shimano R., and Miyauchi K. Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol. 48 (1996) 861-865
42. Itoh T., Ohguchi K., Inhuma M., Nozawa Y., and Asao Y. Inhibitory effect of xanthones isolated from the pericarp of Garcinia Mangostana L. on rat basophilic leukemia RBL-2H3 cell degranulation. Bioorg. Med. Chem. 16 (2008) 4500-4508
43. Jefferson A.Q.A., Scheimann F., and Sim K.Y. Isolation of γ-mangostin from Garcinia Mangostana and preparation of the natural mangostins by selective demethylation. Aust. J. Chem. 23 (1970) 2539-2543
44. Ji X., Avula B., and Khan I.A. Quantitative and qualitative determination of six xanthones in Garcinia mangostana L. by LC-PDA and LC-ESI-MS. J. Pharm. Biomed. Anal. 43 (2007) 1270-1276
45. Jiang D.J., Dai Z., and Li Y.J. Pharmacological effects of xanthones as cardiovascular protective agents. Cardiovasc. Drug. Rev. 22 (2004) 91-102
46. Jinsart W., Ternai B., Buddhasukh D., and Polya G.M. Inhibition of wheat embryo calcium-dependent protein kinase and other kinases by mangostin and γ-mangostin. Phytochemistry 31 (1992) 3711-3713
47. Jung H.A., Su B.N., Keller W.J., Mehta R.G., and Kinghorn D. Antioxidant Xanthones from pericarp of Garcinia mangostana (Mangosteen). J. Agric. Food. Chem. 54 (2006) 2077-2082
48. Komguem J., Meli A.L., Manfouo R.N., Lontsi D., Ngounou F.N., Kuete V., Kamdem H.W., Tane P., Ngadjui B.T., Sondengam B.L., and Connolly J.D. Xanthones from Garcinia smeathmannii (Oliver) and their antimicrobial activity. Phytochemistry 66 (2005) 1713-1717
49. Laphookhieo S., Syers J.K., Kiattansakul R., and Chantrapromma K. Cytotoxic and antimalarial prenylated xanthones from Cratoxylum cochinchinense. Chem. Pharm. Bull. 54 (2006) 745-747
50. Leong L., and Shui G. An investigation of antioxidant capacity of fruits in Singapore markets. Food Chem. 76 (2002) 69-75
51. Likhitwitayawuid K., Phadungcharoen T., and Krungkrai J. Antimalarial xanthones from Garcinia cowa. Planta Med. 64 (1998) 70-72
52. Likhitwitayawuid K., Chanmahasathien W., Ruangrungsi N., and Krungkrai J. Xanthones with antimalarial activity from Garcinia dulcis. Planta Med. 64 (1998) 281-282
53. Liou S.S., Shieh W.L., Cheng T.H., Won S.J., and Lin C.N. γ-Pyrone compounds as potential anti-cancer drugs. J. Pharm. Pharmacol. 45 (1993) 791-794
54. Mahabusarakam W., Wiriyachitra P., and Phongpaichit S. Antimicrobial activities of chemical constituents from G. mangostana Linn. J. Sci. Soc. Thailand 12 (1986) 239-242
55. Mahabusarakam W., Wiriyachtra P., and Taylor W. Chemical constituents of Garcinia mangostana. J. Nat. Prod. 50 (1987) 474-478
56. Mahabusarakam W., Proudfoot J., Taylor W., and Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic. Res. 33 (2000) 643-659
57. Mahabusarakam W., Kuaha K., Wilairat P., and Taylor W.C. Prenilated xanthones as potential antiplasmodial substances. Planta Med. 72 (2006) 912-916
58. Malawska B. New anticonvulsant agents. Curr. Top. Med. Chem. 5 (2005) 69-85
59. Mandal S., Das P.C., and Joshi P.C. Naturally ocurring xanthones of terrestial flora. J. Indian Chem. Soc. 69 (1992) 611-636
60. Matsumoto K., Akao Y., Kobayashi E., Ohguchi K., Ito T., Iinuma M., and Nozawa Y. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J. Nat. Prod. 66 (2003) 1124-1127
61. Matsumoto K., Akao Y., Yi H., Ohguchi K., Ito T., Tanaka T., Kobayashi E., Iinuma M., and Nozawa Y. Preferencial target is mitochondria in α-mangostin-induced apoptosis in human leukemia HL60 cells. Bioorg. Med. Chem. 12 (2004) 5799-5806
62. Matsumoto K., Akao Y., Ohguchi K., Ito T., Tanaka T., Iinuma M., and Nozawa Y. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg. Med. Chem. 13 (2005) 6064-6069
63. Moongkarndi P., Kosem N., Kaslunga S., Luanratana O., Pongpan N., and Neungton N. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J. Ethnopharmacol. 90 (2004) 161-166
64. Moongkarndi P., Kosem N., Luanratana O., Jongsomboonkusol S., and Pongpan N. Antiproliferative activity of Thai medicinal plant extracts on human breast adenocarcinoma cell line. Fitoterapia 75 (2004) 375-377
65. Morton J. Fruits from Warm Climates (1987), Creative Resource Systems Inc., Miami, USA p. 304
66. Murakami M. Uber die Konstitution des Mangostins. Liebigs. Ann. 496 (1932) 122-151
67. Muruganandan S., Srinivasan K., Gupta S., Gupta P.K., and Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J. Ethnopharmacol. 97 (2005) 497-501
68. Nabandith V., Suzui M., Morioka T., Kaneshiro T., Kinjo T., Matsumoto K., Akao Y., Iinuma M., and Yoshimi N. Inhibitory effects of crude α-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac. J. Cancer Prev. 5 (2004) 433-438
69. Nakagawa Y., Iinuma M., Naoe T., Nozawa Y., and Akao Y. Characterized mechanism of α-mangostin-induced cell death: Caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miRNA-143 expression in human colorectal cancer DLD-1 cells. Bioorg. Med. Chem. 15 (2007) 5620-5628
70. Nakatani K., Nakahata N., Arakawa T., Yasuda H., and Ohizumi Y. Inhibition of cyclooxygenase and prostaglandin E2 syntesis by γ-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells. Biochem. Pharmacol. 63 (2002) 73-79
71. Nakatani K., Atsumi M., Arakawa T., Oosawa K., Shimura S., Nakahata N., and Ohizumi Y. Inhibitions of histamine release and prostaglandin E2 synthesis by mangosteen, a Thai medicinal plant. Biol. Pharm. Bull. 25 (2002) 1137-1141
72. Nakatani K., Yamakuni T., Kondo N., Arakawa T., Oosawa K., Shimura S., Inoue H., and Ohizumi Y. γ-Mangostin inhibits inhibitor-kappaB kinase activity and decreases lipopolysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma cells. Mol. Pharmacol. 66 (2004) 667-674
73. Nilar, and Harrison L.J. Xanthones from the heartwood of Garcinia mangostana. Phytochemistry 60 (2002) 541-548
74. Nilar, Nguyen L.H.D., Venkatraman G., Sim K.Y., and Harrison L.J. Xanthones and benzophenones from Garcinia griffithii and Garcinia mangostana. Phytochemistry 66 (2005) 1718-1723
75. Parveen M., and Khan N.U. Two xanthones from Garcinia mangostana. Phytochemistry 27 (1988) 3694-3696
76. Pedro M., Cerqueira F., Sousa M.E., Nascimento M.S., and Pinto M. Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg. Med. Chem. 10 (2002) 3725-3730
77. Peres V., and Nagem T.J. Tryoxigenated naturally ocurring xanthones. Phytochemistry 44 (1996) 191-214
78. Peres V., Nagem T.J., and Faustino de Oliveira F. Tetraoxygenated naturally occurring xantones. Phytochemistry 55 (2000) 683-710
79. Phongpaichit S., Ongsakul M., Nilrat L., Tharavichitkul P., Bunchoo S., Chuaprapaisilp T., and Wiriyachitra P. Antibacterial activities of extracts from Garcinia mangostana pericarps on methicillin-resistant Staphylococcus aureus and Enterococcus species. Songklanakarin J. Sci. Technol. 16 (1994) 399-405
80. Pierce S.C. A Thai Herbal (2003), Findhorn Press, Scotland, UK p. 118
81. Pinto M.M., Sousa M.E., and Nascimento M.S. Xanthone derivatives: new insights in biological activities. Curr. Med. Chem. 12 (2005) 2517-2538
82. Rassameemasmaung S., Sirikulsathean A., Amornchat C., Hirunrat K., Rojanapanthu P., and Gritsanapan W. Effects of herbal mouthwash containing the pericarp extract of Garcinia mangostana L. on halitosis, plauque and papillary bleeding index. J. Int. Acad. Periodontol. 9 (2007) 19-25
83. Riscoe M., Kelly J.X., and Winter R. Xanthones as antimalarial agents: discovery, mode of action, and optimization. Curr. Med. Chem. 12 (2005) 2539-2549
84. Sakagami Y., Iinuma M., Piyasena K.G.N.P., and Dharmaratne H.R.W. Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine 12 (2005) 203-208
85. Sakai S., Katsura M., Takayama H., Aimi N., Chokethaworn N., and Suttajit M. The structure of garcinome E. Chem. Pharm. Bull. 41 (1993) 958-960
86. Saralamp P., Chuakul W., Temsirirkkul R., and Clayton T. Medicinal Plants in Thailand vol. 1 (1996), Department of Pharmaceutical Botany, Faculty of Pharmacy, Bangkok, Thailand p. 98
87. Schmid W. Ueber das mangostin. Liebigs. Ann. Chem. 93 (1855) 83-89
88. Sen A.K., Sarkar K.K., Majumder P.C., and Banerji N. Isolation of three new minor xanthones from Garcinia mangostana Linn. Indian J. Chem. 19B (1980) 1008
89. Sen A.K., Uusvuori R., Hase T.A., Benerji N., Sarkar K.K., and Mazumder P.C. A xanthone from Garcinia mangostana. Phytochemistry 19 (1980) 2223-2225
90. Sen A.K., Uusvuori R., Hase T.A., Banerji N., Sarkar K.K., and Mazumder P.C. The structures of garcinones A, B and C: three new xanthones from Garcinia mangostana. Phytochemistry 21 (1982) 1747-1750
91. Sen A.K., Sarkar K.K., Majumder P.C., and Banerji N. Garcinone-D, a new xanthone from Garcinia mangostane Linn. Indian J. Chem. 25B (1986) 1157-1158
92. Shankaranarayan D., Gopalakrishnan C., and Kameswaran L. Pharmacological profile of mangostin and its derivatives. Arch. Int. Pharmacodyn. Ther. 239 (1979) 257-269
93. Sia G.L., Bennett G.J., Harrison L.J., and Sim K.Y. Minor xanthones from the bark of Cratoxylum cochinchinense. Phytochemistry 38 (1995) 1521-1528
94. Somanathan R., and Sultanbawa M.U.S. Chemical investigation of Ceylonese plants. Part 1, Extractives of Calophyllum calaba L. and Calophyllum bracteatum Thw. (Guttiferae). J. Chem. Soc. Perkin Trans. I (1972) 1935-1943
95. Souza M.E., and Pinto M.M.M. Síntesis of xanthones: an overview. Curr. Med. Chem. 12 (2005) 2447-2479
96. Stout G.H., and Krahn M.M. The structure of mangostin. Chem. Commun. (1968) 211-212
97. Suksamrarn S., Suwannapoch N., Ratananukul P., Aroonlerk N., and Suksamrarn A. Xanthones from the green fruit hulls of Garcinia mangostana. J. Nat. Prod. 65 (2002) 761-763
98. Suksamrarn S., Suwannapoch N., Phakhodee W., Thanuhiranlert J., Ratananukul P., Chimnoi N., and Suksamrarn A. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem. Pharm. Bull. 51 (2003) 857-859
99. Suksamrarn S., Komutiban O., Ratananukul P., Chimnoi N., Lartpornmatulee N., and Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem. Pharm. Bull. 54 (2006) 301-305
100. Sultanbawa M.U.S. Xanthonoids of tropical plants. Tetrahedron 36 (1980) 1465-1506
101. Sundaram B.M., Gopalakrishnan C., Subramanian S., Shankaranarayanan D., and Kameswaran L. Antimicrobial activities of Garcinia mangostana. Planta Med. 48 (1983) 59-60
102. Vieira L.M., and Kijjoa A. Naturally-occurring xanthones: recent developments. Curr. Med. Chem. 12 (2005) 2413-2446
103. Vlietinck A.D.B.T., Apers S., and Pieters L. Plant-derived leading compounds for chemotheraphy of human immunodeficiency virus (HIV) infection. Planta Med. 64 (1998) 97-109
104. Voravuthikunchai S.P., and Kitpipit L. Activity of medicinal plant extracts against hospital isolates of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 11 (2005) 510-512
105. Walker E.B. HPLC analysis of selected xanthones in mangosteen fruit. J. Sep. Sci. 30 (2007) 1229-1234
106. Wan A.S.C. Garcinia mangostana. High resolution NMR studies of mangostin. Planta Med. 24 (1973) 297-300
107. Weecharangsan W., Opanasopit P., Sukma M., Ngawhirunpat T., Sotanaphun U., and Siripong P. Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.). Med. Princ. Pract. 15 (2006) 281-287
108. Westerman P.W., Gunasekera S.P., Uvais M., Sultanbawa S., and Kazlauskas R. Carbon-13 N.m.r stuyd of naturally occuring xanthones. Organ. Magnet. Res. 9 (1977) 631-636
109. Williams P., Ongsakul M., Proudfoot J., Croft K., and Beilin L. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Radic. Res. 23 (1995) 175-184
110. Yamakuni T., Aoki K., Nakatani K., Kondo N., Oku H., Ishiguro K., and Ohizumi Y. Garcinone B reduces prostaglandin E2 release and NF-kappaB-mediated transcription in C6 rat glioma cells. Neurosci. Lett. 394 (2006) 206-210
111. Yates P., and Bhat H.B. Structure of β-mangostin. Can. J. Chem. 46 (1968) 3770-3772
112. Yates P., and Stout G.H. The structure of mangostin. J. Am. Chem. Soc. 80 (1958) 1691-1700
113. Yoshikawa M., Harada E., Miki A., Tsukamoto K., Si Qian L., Yamahara J., and Murakami N. Antioxidant constituents from the fruit hulls of mangosteen (Garcinia mangostana L.) originating in Vietnam. Yakugaku Zasshi 114 (1994) 129-133